NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/20/2023
Back to search
Official data from USPTO
NANOPHARMA SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
06/20/2023
Trademark type
Combined
Nice classes
42
Filing date
04/20/2021
Registration date
06/20/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/20/2023
Last transaction
06/20/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
09/01/2020
First use in commerce
09/01/2020
Drawing code
3
Owner type
03
Owner location
San Diego, CA, US
Examiner
CLARKE, NANCY
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the phrase "NANOPHARMA SOLUTIONS" in stylized letters underneath a stylized symbol resembling a six-pointed star with two arrows. One of the two arrows forms part of the six-pointed star, and points up. The other arrow points down. The wording "NANOPHARMA" is in black, the wording "SOLUTIONS" is in light blue, the arrow pointing up is in royal blue, and the rest of the star design and the arrow pointing down are in light blue.
Holders and representatives
Holders
Nano PharmaSolutions
Representatives
Barry F. Soalt Procopio Cory Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services; Pharmaceutical products development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific researchbiochemical researchpharmaceutical research in the field of generation of nano drug particles used to enhance the bioavailability of otherwise poorly soluble drugs; Scientific study and research in the fields of drug delivery and development of pharmaceuticals comprised of nano drug particles; Testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/20/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/22/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/22/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/22/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/22/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/22/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/22/2023
GNRT
NON-FINAL ACTION E-MAILED
02/22/2023
CNRT
NON-FINAL ACTION WRITTEN
02/22/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/12/2023
GNRT
NON-FINAL ACTION E-MAILED
01/12/2023
CNRT
NON-FINAL ACTION WRITTEN
01/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/08/2022
ALIE
ASSIGNED TO LIE
10/08/2022
NREV
NOTICE OF REVIVAL - E-MAILED
08/30/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/29/2022
PETG
PETITION TO REVIVE-GRANTED
08/29/2022
PROA
TEAS PETITION TO REVIVE RECEIVED
08/29/2022
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
06/27/2022
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
06/27/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/13/2021
GNRT
NON-FINAL ACTION E-MAILED
12/13/2021
CNRT
NON-FINAL ACTION WRITTEN
12/13/2021
DOCK
ASSIGNED TO EXAMINER
12/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/28/2021
NWAP
NEW APPLICATION ENTERED
04/23/2021
Continuous trademark protection
Get notified about every new filing that threatens NANOPHARMA SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.